Search results for ‘Subject term:"learning disabilities"’ Sort:
Results 1 - 6 of 6
The use of psychotropic medication for people with learning disabilities
- Authors:
- KROESE Biza Stenfert, HOLMES Guy
- Journal article citation:
- Tizard Learning Disability Review, 10(4), October 2005, pp.19-22.
- Publisher:
- Emerald
The authors comment on articles written by Heslop et al and Lim in Learning Disability Review 10(4) and also highlight on aspects of their own earlier review of the use of psychotropic drugs for people with learning disabilities.
Learning difficulties
- Author:
- WARD Linda
- Journal article citation:
- Research Matters, 19, April 2005, pp.23-28.
- Publisher:
- Community Care
Reports on the Medical Matter research project, undertaken by the Norah Fry Research Centre, University of Bristol in partnership with Aspects and Milestones Trust and HFT (a local and national learning difficulties services provider respectively) to investigate the understanding people with learning difficulties and their carers have about the psychotropic medication they are prescribed. Five co-researchers were recruited to work along the Norah Fry team and a sample of 21 people with learning difficulties took part in the study. Results found that most people with learning difficulties knew little about their medication and if they did receive information it was usually through their carer. Offers recommendations for improving practice.
Medication matters: final report
- Author:
- NORAH FRY RESEARCH CENTRE. Medication Matters Team
- Publisher:
- Norah Fry Research Centre
- Publication year:
- 2007
- Pagination:
- 31p.
- Place of publication:
- Bristol
The aim of this project was to find out what people with learning difficulties, their carers and the prescribers of their medication understand about why psychotropic medication has been prescribed and what the implications of taking it are. Interviews were held with 21 people with learning difficulties living in four different regions of England. They were contacted via voluntary and statutory sector organisations providing support for people with learning difficulties living in those areas. People were selected on the basis that they had learning difficulties and had been prescribed psychotropic medication. The majority of people interviewed thought that people with learning difficulties should be given the same information about their medication as anyone else, in an easy to understand format. As a result of the research findings, the research team have been working on a number of resources to help people with learning difficulties, their carers and prescribers. These are: a booklet for people with learning difficulties, their families or carers where information about a medication can be recorded; a decision-making tool for people with learning difficulties to help them make informed choices about medications they are prescribed; and information about where to find out more about medications.
The knowledge people with learning disabilities and their carers have about psychotropic medication
- Authors:
- HESLOP Pauline, FOLKES Liz, RODGERS Jackie
- Journal article citation:
- Tizard Learning Disability Review, 10(4), October 2005, pp.10-18.
- Publisher:
- Emerald
Psychotropic medications are a treatment commonly used for people with learning disabilities. Legislation and guidance suggest that, for a person to give informed consent to treatment, they must have knowledge of the potential treatment. This study of 21 people with learning disabilities, and their carers and prescribers, living in four different regions of England, suggests that few of the people with learning disabilities were fully informed about their treatment. Many of their carers said that although they know how to administer the medication, they know little about why the person was taking it and what the implications might be. Despite this, people with learning disabilities made the general assumption that carers would, or should, know everything about their medication. The current provision of information to people with learning disabilities and carers was found to be poor. For key strategies identified in supporting people with learning disabilities in obtaining information about medication were spending more time providing and reiterating key information, providing accurate, up-to-date, accessible information about medication, providing training for carers in wider aspects of medication usage, and tailoring information to each person's individual needs.
Do people with intellectual disabilities understand their prescription medication? A scoping review
- Authors:
- SMITH Megan V. A., et al
- Journal article citation:
- Journal of Applied Research in Intellectual Disabilities, 32(6), 2019, pp.1375-1388.
- Publisher:
- Wiley
Background: People with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects. Method: A scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved. Results: Ten journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities. Conclusion: There is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards. (Publisher abstract)
Psychiatric drugs explained
- Author:
- HEALY David
- Publisher:
- Churchill Livingstone
- Publication year:
- 2002
- Pagination:
- 343p.bibliog.
- Place of publication:
- Edinburgh
- Edition:
- 3rd
Provides a guide to the uses, benefits and impact of psychotropic drugs, addressing the key concerns for health professionals around compliance, partnerships in treatment options and issues of accountability in practice. The book also contains a section on the pharmacological industry, critically appraising its significant role in the diagnosis and treatment of mental disorders. The major drug categories are listed and the clinical uses, modes of action and side effects of drugs in each category are described. Contents include: management of psychoses; management of affective disorders; use of psychos; management of sleep disorders and insomnia; management of cognitive impairment; management of sexual difficulties; management of dependence and withdrawal; consent, abuse and liability; the marketing of tranquility.